{"id":1194,"date":"2018-12-02T13:00:35","date_gmt":"2018-12-02T05:00:35","guid":{"rendered":"https:\/\/credevo.com\/articles\/\/?p=1194"},"modified":"2021-09-20T19:52:29","modified_gmt":"2021-09-20T11:52:29","slug":"clinical-trial-regulatory-process-mexico","status":"publish","type":"post","link":"https:\/\/credevo.com\/articles\/2018\/12\/02\/clinical-trial-regulatory-process-mexico\/","title":{"rendered":"Clinical Trial Regulatory Process &#8211; Mexico"},"content":{"rendered":"\n<p><strong>Mexico<\/strong> is&nbsp;rapidly becoming a major player in the pharmaceutical and medical device industries. A recent report states that It\u2019s the number one exporter of medical devices in Latin America and 8th in the world&nbsp;and also a leading exporter of pharmaceutical products in Latin America.<\/p>\n\n\n\n<div class=\"wp-block-image\"><figure class=\"aligncenter is-resized\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/credevo.com\/articles\/\/wp-content\/uploads\/2018\/12\/Clinical_trial_regulatory_process_Procedure_Mexico_credevo-300x169.jpg\" alt=\"\" class=\"wp-image-1374\" width=\"640\" height=\"361\" srcset=\"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2018\/12\/Clinical_trial_regulatory_process_Procedure_Mexico_credevo-300x169.jpg 300w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2018\/12\/Clinical_trial_regulatory_process_Procedure_Mexico_credevo-768x432.jpg 768w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2018\/12\/Clinical_trial_regulatory_process_Procedure_Mexico_credevo-1024x576.jpg 1024w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2018\/12\/Clinical_trial_regulatory_process_Procedure_Mexico_credevo-732x412.jpg 732w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2018\/12\/Clinical_trial_regulatory_process_Procedure_Mexico_credevo-1140x641.jpg 1140w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2018\/12\/Clinical_trial_regulatory_process_Procedure_Mexico_credevo.jpg 1920w\" sizes=\"(max-width: 640px) 100vw, 640px\" \/><\/figure><\/div>\n\n\n\n<p>Having&nbsp;a diverse demographic profile&nbsp;gives&nbsp;the enormous potential for the recruitment of patients on a large scale. Researchers have experience in all therapeutic areas and population groups with experience in implementing a diverse epidemiological profile.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">About Mexico<\/h2>\n\n\n\n<p>Located between the United States and Central America, Mexico\u2019s geography and Spanish language put it in an ideal position to act as a gateway to Latin American pharmaceutical markets.<\/p>\n\n\n\n<p>With an estimated size of $10 billion in 2016, the country\u2019s pharmaceutical market ranks twelfth globally with a stable economy although it is classified as upper-middle-income, it also offers lower costs&nbsp;compared with other countries.<\/p>\n\n\n\n<h5 class=\"wp-block-heading\"><strong>Clinical Trial Overview<\/strong><\/h5>\n\n\n\n<ul class=\"wp-block-list\"><li>Clinical Trial Application language is <strong><em>Spanish<\/em><\/strong><\/li><li>The type<strong><em> of approval is Sequential<\/em><\/strong><\/li><li><span style=\"background-color: rgba(30, 30, 30, 0.2);\"><b><i>An in-country<\/i><\/b><\/span> <strong><em>Representative<\/em><\/strong> or<strong><em> Sponsor<\/em><\/strong> is required<\/li><\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">What is the Clinical trial Regulatory in MEXICO?<\/h2>\n\n\n\n<p>Any research on human beings which includes testing new medicinal products and new uses, as well as dosages and administration routes for already approved medicinal products are approved by the <strong>Federal Commission for Protection Against Sanitary Risk (COFEPRIS &#8211; Comisi\u00f3n Federal para la Protecci\u00f3n contra Riesgos Sanitarios)<\/strong>.<\/p>\n\n\n\n<p>The Federal Commission for the Protection against Sanitary Risk (COFEPRIS) is classified as a Level 4 national regulatory authority by the Pan American Health Organization\/World Health Organization (PAHO\/WHO) and has signed bilateral agreements with other regulatory agencies that recognize registrations made by COFEPRIS.<\/p>\n\n\n\n<p>Clinical trials for innovator biological products must take place in Mexico&nbsp;for the product to be manufactured in Mexico. For products manufactured abroad, the Ministry of Health can request a clinical trial in Mexico when the Sub-Committee on Evaluation of Biotechnological Products of COFEPRIS considers that this is necessary.<\/p>\n\n\n\n<p>For any regulatory inquiries, the applicant can visit <a href=\"https:\/\/www.gob.mx\/cofepris\/acciones-y-programas\/cis\">Integral Services Center<\/a> or <a href=\"mailto:contactociudadano@cofepris.gob.mx\">contactociudadano@cofepris.gob.mx<\/a>, <a href=\"mailto:contacto@cofepris.gob.mx\">contacto@cofepris.gob.mx<\/a><\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Ethics Committee<\/h2>\n\n\n\n<ul class=\"wp-block-list\"><li>Mexico has a decentralized registration process for <strong>Research Ethics Committees (REC)<\/strong> operating through the <a href=\"https:\/\/www.gob.mx\/salud\/conbioetica\"><strong>National Bioethics Commission<\/strong><\/a><\/li><li><strong>REC &#8211; Research Ethics Committee<\/strong> and <strong>RC &#8211; Research Committees<\/strong>&nbsp;approval is required for each trial site where a study is being conducted, and when applicable, <strong>Biosafety Committees (BC)<\/strong> approval is required as well<\/li><li><strong>Research Committees (RCs)<\/strong> and <strong>Biosafety Committees (BC)<\/strong> within each health institution must register with the <strong>Federal Commission for the Protection Against Sanitary Risks (COFEPRIS)<\/strong> where the study is being conducted<\/li><li><strong>REC<\/strong> must approve the informed consent document and evaluates the technical quality and scientific merit of the proposed research.<\/li><li>The <strong>BC<\/strong> is responsible for determining and regulating the use of ionizing radiation or genetic engineering techniques within the health institution<\/li><li>The <strong>REC<\/strong> and <strong>COFEPRIS<\/strong> reviews may not be conducted in parallel.<\/li><\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Site Selection<\/h2>\n\n\n\n<ul class=\"wp-block-list\"><li>The sponsor is responsible for selecting each research center and ensure that <strong>COFEPRIS<\/strong> has authorized the site for operation<\/li><li>The sponsor or his\/her contract research organization (CRO) should comply with the <a href=\"http:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Efficacy\/E6\/E6_R1_Guideline.pdf\">Guideline for Good Clinical Practice.<\/a><\/li><\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">What are the requirements for approval?<\/h2>\n\n\n\n<p>All documentation related to submitting applications for research protocol authorization is required to be in <em>Spanish<\/em>, no documentation (e.g., protocol and researcher\u2019s manual) should be submitted in English.<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>Approval from an independent ethics committee registered with the Ministry of Health;<\/li><li>Approval from the medical institution or institutions where the clinical trials will be conducted;<\/li><li>COFEPRIS approval for institutions to conduct clinical trials;<\/li><li>Clinical trial protocol (including a schedule and the approximate amount of medicinal products to be imported);<\/li><li>Written informed consent templates;<\/li><li>Pre-clinical and clinical data that justify conducting the research;<\/li><li>Description of available resources to conduct the research and to address emergencies (including a statement of sponsorship) and<\/li><li>A written letter by the qualified investigator acknowledging his or her responsibilities, and data from the qualified investigator and his or her staff.<\/li><\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">What is the type of Approval?<\/h2>\n\n\n\n<p>The type of approval is <strong><em>Sequential<\/em><\/strong>, where the Sponsor or applicant should first obtain approval from Ethics before getting approval from <strong>COFEPRIS<\/strong>.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Process for Approval<\/h2>\n\n\n\n<ol class=\"wp-block-list\"><li><strong>Step 1<\/strong>: The process starts with an evaluation of the proposed trial at the host institution by the respective Ethics committee, Research committee, and Biosafety Committee. This step may take between three and six months.<\/li><li>Step 2: The second step may have two different Processes. In the most established process or pathway, <strong>COFEPRIS<\/strong> makes an analysis and decision, which may take up to 90 days.<\/li><li>Rather than submitting the application directly, the applicant&nbsp;can first choose to obtain a pre-assessment evaluation of the application through an <strong>Enabled Pre-Assessment Support Unit (Unidad Habilitada de Apoyo al Predictamen (UHAP)<\/strong> fee for which is 60,000 Mexican Pesos<\/li><li>The advantage of this additional evaluation is that once a <strong>UHAP<\/strong> issues a favorable letter of pre-authorization, which may help in guidance and possibility for rejection for the applicant in <strong>COFEPRIS&nbsp;<\/strong>and may include this response with&nbsp; submission to<strong> COFEPRIS<\/strong> through the CIS to be reviewed by the EC<\/li><li>Receipt of a favorable pre-evaluation assessment also requires the EC to issue a response within a maximum of 30 business days as long as the applicant notifies the EC that his\/her application was submitted with the pre-evaluation assessment.<\/li><li>If the applicant selects a scientific committee within an institution that has a UHAP and the cost is 40,000 Mexican Pesos. The cost for each amendment is 3,500 Mexican Pesos, and corrections to the pre-assessment document are free.<\/li><li>This newer pathway which uses Enabled Support Units for Preauthorization (UHAPs) will review and preauthorize trials in 45 days, followed by a COFEPRIS analysis that must offer a decision in 30 days.<\/li><li>Once COFEPRIS issues an approval, the applicant has a maximum of five (5) working days to enter this information into the <a href=\"http:\/\/siipris03.cofepris.gob.mx\/Resoluciones\/Consultas\/ConWebRegEnsayosClinicos.asp\"><strong>National Registry of Clinical Trials (Registro Nacional de Ensayos Cl\u00ednicos (RNEC)<\/strong><\/a> and importation of new drugs needs to be authorized, which may take an additional 15 days.<\/li><\/ol>\n\n\n\n<div class=\"wp-block-image\"><figure class=\"aligncenter is-resized\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/credevo.com\/articles\/\/wp-content\/uploads\/2019\/02\/Clinical_trial_regulatory_process_mexico_credevo-300x268.png\" alt=\"\" class=\"wp-image-1195\" width=\"498\" height=\"445\" srcset=\"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2019\/02\/Clinical_trial_regulatory_process_mexico_credevo-300x268.png 300w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2019\/02\/Clinical_trial_regulatory_process_mexico_credevo.png 556w\" sizes=\"(max-width: 498px) 100vw, 498px\" \/><\/figure><\/div>\n\n\n\n<h6 class=\"wp-block-heading\"><strong>UHAP<\/strong>:&nbsp;Pre-Assessment Support Unit (Unidad Habilitada de Apoyo al Predictamen,<\/h6>\n\n\n\n<h6 class=\"wp-block-heading\"><strong>COFEPRIS<\/strong>: Comisi\u00f3n Federal para la Protecci\u00f3n contra Riesgos Sanitarios &#8211; Federal Commission for Protection Against Sanitary Risk<\/h6>\n\n\n\n<h2 class=\"wp-block-heading\">What is the Timeline for approval?<\/h2>\n\n\n\n<ul class=\"wp-block-list\"><li><strong>COFEPRIS<\/strong> must approve a request for research protocol authorization within 30 working days from the day following an application\u2019s filing.<\/li><li>According to <strong>COFEPRIS<\/strong>, currently takes on average 10 months. The process starts with an evaluation at the host institution by the respective ethics committee, research committee, and biosafety committee where this step may take between three and six months.<\/li><\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Fee structure<\/h2>\n\n\n\n<ul class=\"wp-block-list\"><li>Research Ethics Committees (RECs) do not charge sponsors\/investigators for review.<\/li><li>The health institution must finance REC operating expenses, without this causing any conflict of interest in the committee\u2019s functions.<\/li><li>For fee and other required details, the applicant can visit <a href=\"https:\/\/www.gob.mx\/cofepris\/acciones-y-programas\/cis\">Integral Services Center <\/a><\/li><\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Bioequivalence and Bio-analysis studies<\/h2>\n\n\n\n<p><strong>Bioequivalence<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>The pharmaceutical market in Mexico is divided into patented medicines 51 percent, generics with 35 percent, and OTC products with the remaining 14 percent of the market by value. According to the Federal Commission for the Protection Against Sanitary Risks (COFEPRIS), the country\u2019s regulatory authority for the sector, generics represent more than 80 percent of the market in terms of volume.<\/li><li>Mexico regulations for registration of generic products require proof of therapeutic bioequivalence in order to allow health&nbsp;authorities to declare interchangeability between the non-innovator product (the&nbsp;generic product) and the reference product.<\/li><li>A company can submit a dossier for approval of a biocomparable to COFEPRIS eight years prior to the expiration of the patent on the originator biological, however, approval for the biocomparable will only be granted at the end of the term of the patent.<\/li><li>Mexico does not accept foreign comparators and&nbsp;accept bioequivalence studies involving only their&nbsp;local comparator products<\/li><li>Companies have to provide information concerning dissolution profiles or bioavailability studies regarding the reference product. COFEPRIS periodically issues a list of reference medicinal products.<\/li><\/ul>\n\n\n\n<p><strong>Bio-analysis&nbsp;<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>The Federal Commission for the Protection against Sanitary Risk (COFEPRIS) is in charge of regulating BA laboratories<\/li><li>According to Mexican regulations, all steps for a BE study should be conducted inside the country.<\/li><li>A \u2018restraint of trade\u2019 is likely to rise, which means that BA laboratories outside the country could be authorized to perform analysis by Mexican authorities.<\/li><\/ul>\n\n\n\n<h4 class=\"wp-block-heading\">Dossier requirements for submission to Regulatory bodies<\/h4>\n\n\n\n<ul class=\"wp-block-list\"><li>Dossiers to be submitted in local language<\/li><li>CPP \/ WHO GMP \/ Manufacturing license<\/li><li>Free Sale Certificate<\/li><li>Letter of Authorization \/ Power of Attorney<\/li><li>Legalization of administrative documents from the embassy<\/li><li>API Technical package (Brazil, Mexico)<\/li><li>Specification and methods<\/li><li>COA of API and Excipients from vendors<\/li><li>Manufacturing procedure and controls<\/li><li>Executed Batch manufacturing records \/ Batch Numbering system.<\/li><li>Stability data on three batches of Stability conditions as per zone definitions.<\/li><\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">What about Good Clinical Practice &#8211; GCP?<\/h2>\n\n\n\n<p>GCP in Mexico is well regulated. Although the regulation is robust, there is scope for improvement. Currently, efforts are in place to reach international standards.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">What are the Insurance requirements for Clinical Trials?<\/h2>\n\n\n\n<p>The clinical trial budget should include compensation to which the subject of the investigation will be legally entitled in case of damages directly related to the clinical trial. Where appropriate, this financial fund can be covered under study insurance.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Import and Export of Biological Specimens<\/h2>\n\n\n\n<ul class=\"wp-block-list\"><li>Applicant should submit an import\/export permit in print or electronically. For details visit <a href=\"https:\/\/www.gob.mx\/cms\/uploads\/attachment\/file\/350081\/COFEPRIS-01-024.pdf\">Import and Export<\/a><\/li><li>Institutions that dispense or import products of human beings including tissues, cells, blood, and its components must comply with specific COFEPRIS documentation submission requirements to apply for an import permit.<\/li><\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Clinical Trial Numbers Overview<\/h2>\n\n\n\n<p>A total of 3282 studies were registered till date with 754 Ongoing studies.<\/p>\n\n\n\n<p>Major therapeutic area of studies are<\/p>\n\n\n\n<ol class=\"wp-block-list\"><li>Immune disorders<\/li><li>Metabolic disorders<\/li><li>Respiratory diseases &amp;<\/li><li>Communicable diseases&nbsp;<\/li><\/ol>\n\n\n\n<h2 class=\"wp-block-heading\"><img loading=\"lazy\" decoding=\"async\" class=\"size-large wp-image-1251 aligncenter\" src=\"https:\/\/credevo.com\/articles\/\/wp-content\/uploads\/2019\/03\/Mexico_Clinical_trial_regulatory_process_Credevo_.jpg-1024x576.jpg\" alt=\"\" width=\"750\" height=\"422\" srcset=\"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2019\/03\/Mexico_Clinical_trial_regulatory_process_Credevo_.jpg-1024x576.jpg 1024w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2019\/03\/Mexico_Clinical_trial_regulatory_process_Credevo_.jpg-300x169.jpg 300w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2019\/03\/Mexico_Clinical_trial_regulatory_process_Credevo_.jpg-768x432.jpg 768w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2019\/03\/Mexico_Clinical_trial_regulatory_process_Credevo_.jpg-732x412.jpg 732w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2019\/03\/Mexico_Clinical_trial_regulatory_process_Credevo_.jpg-1140x641.jpg 1140w, https:\/\/credevo.com\/articles\/wp-content\/uploads\/2019\/03\/Mexico_Clinical_trial_regulatory_process_Credevo_.jpg.jpg 1920w\" sizes=\"(max-width: 750px) 100vw, 750px\" \/><\/h2>\n\n\n\n<hr class=\"wp-block-separator\"\/>\n\n\n\n<h2 class=\"wp-block-heading\"><em>Need more info on Mexico?<\/em><\/h2>\n\n\n\n<p>Discuss with Credevo about your needs for clinical research that could be fulfilled in Mexico. Know more from our experts. Shoot your questions to us.<\/p>\n\n\n<div class=\"wpforms-container wpforms-container-full\" id=\"wpforms-1243\"><form id=\"wpforms-form-1243\" class=\"wpforms-validate wpforms-form\" data-formid=\"1243\" method=\"post\" enctype=\"multipart\/form-data\" action=\"\/articles\/wp-json\/wp\/v2\/posts\/1194\" data-token=\"f7863443dc2f110d545142c2ee685b96\" data-token-time=\"1776937948\"><noscript class=\"wpforms-error-noscript\">Please enable JavaScript in your browser to complete this form.<\/noscript><div class=\"wpforms-field-container\"><div id=\"wpforms-1243-field_6-container\" class=\"wpforms-field wpforms-field-textarea\" data-field-id=\"6\"><label class=\"wpforms-field-label\" for=\"wpforms-1243-field_6\">What kind of support do you need in Mexico? <span class=\"wpforms-required-label\">*<\/span><\/label><textarea id=\"wpforms-1243-field_6\" class=\"wpforms-field-medium wpforms-field-required\" name=\"wpforms[fields][6]\" required><\/textarea><\/div><div id=\"wpforms-1243-field_1-container\" class=\"wpforms-field wpforms-field-email\" data-field-id=\"1\"><label class=\"wpforms-field-label\" for=\"wpforms-1243-field_1\">What is your work email? <span class=\"wpforms-required-label\">*<\/span><\/label><input type=\"email\" id=\"wpforms-1243-field_1\" class=\"wpforms-field-medium wpforms-field-required\" name=\"wpforms[fields][1]\" spellcheck=\"false\" required><div class=\"wpforms-field-description\">Provide your work email, where we can contact you<\/div><\/div><\/div><!-- .wpforms-field-container --><div class=\"wpforms-field wpforms-field-hp\"><label for=\"wpforms-1243-field-hp\" class=\"wpforms-field-label\">Message<\/label><input type=\"text\" name=\"wpforms[hp]\" id=\"wpforms-1243-field-hp\" class=\"wpforms-field-medium\"><\/div><div class=\"wpforms-recaptcha-container wpforms-is-recaptcha wpforms-is-recaptcha-type-v2\" ><div class=\"g-recaptcha\" data-sitekey=\"6LeaQRYTAAAAAPo7U8jnZJBUndxcS3f0E3Vijb2k\"><\/div><input type=\"text\" name=\"g-recaptcha-hidden\" class=\"wpforms-recaptcha-hidden\" style=\"position:absolute!important;clip:rect(0,0,0,0)!important;height:1px!important;width:1px!important;border:0!important;overflow:hidden!important;padding:0!important;margin:0!important;\" data-rule-recaptcha=\"1\"><\/div><div class=\"wpforms-submit-container\" ><input type=\"hidden\" name=\"wpforms[id]\" value=\"1243\"><input type=\"hidden\" name=\"page_title\" value=\"\"><input type=\"hidden\" name=\"page_url\" value=\"https:\/\/credevo.com\/articles\/wp-json\/wp\/v2\/posts\/1194\"><input type=\"hidden\" name=\"url_referer\" value=\"\"><button type=\"submit\" name=\"wpforms[submit]\" id=\"wpforms-submit-1243\" class=\"wpforms-submit\" data-alt-text=\"Sending...\" data-submit-text=\"Submit\" aria-live=\"assertive\" value=\"wpforms-submit\">Submit<\/button><\/div><\/form><\/div>  <!-- .wpforms-container -->\n\n\n\n<hr class=\"wp-block-separator\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">Reference<\/h3>\n\n\n\n<ol class=\"wp-block-list\"><li><a href=\"https:\/\/www.medpace.com\/spotlight-on-mexico\/\">https:\/\/www.medpace.com\/spotlight-on-mexico\/<\/a><\/li><li><a href=\"https:\/\/www.clinicalleader.com\/doc\/can-mexico-become-a-regional-powerhouse-for-clinical-trials-0001\">https:\/\/www.clinicalleader.com\/doc\/can-mexico-become-a-regional-powerhouse-for-clinical-trials-0001<\/a><\/li><li><a href=\"https:\/\/www.lexology.com\/library\/detail.aspx?g=fbe74b04-fe97-4340-8e18-bbc0dbc1b36d\">https:\/\/www.lexology.com\/library\/detail.aspx?g=fbe74b04-fe97-4340-8e18-bbc0dbc1b36d <\/a><\/li><li><a href=\"https:\/\/clinregs.niaid.nih.gov\/country\/mexico#vulnerable_populations\">https:\/\/clinregs.niaid.nih.gov\/country\/mexico#vulnerable_populations<\/a><\/li><li><a href=\"http:\/\/new.paho.org\/hq\/dmdocuments\/2008\/WG-BE%20document%20eng%20221008.pdf\">http:\/\/new.paho.org\/hq\/dmdocuments\/2008\/WG-BE%20document%20eng%20221008.pdf<\/a><\/li><li><a href=\"https:\/\/www.future-science.com\/doi\/full\/10.4155\/bio.11.67\">https:\/\/www.future-science.com\/doi\/full\/10.4155\/bio.11.67<\/a><\/li><li><a href=\"https:\/\/clinicaltrials.gov\/ct2\/results?recrs=ad&amp;cntry=MX&amp;map_cntry=MX\">https:\/\/clinicaltrials.gov\/ct2\/results?recrs=ad&amp;cntry=MX&amp;map_cntry=MX<\/a><\/li><\/ol>\n","protected":false},"excerpt":{"rendered":"<p>Mexico is&nbsp;rapidly becoming a major player in the pharmaceutical and medical device industries. A recent report states that It\u2019s the number one exporter of medical devices in Latin America and 8th in the world&nbsp;and also a leading exporter of pharmaceutical products in Latin America. Having&nbsp;a diverse demographic profile&nbsp;gives&nbsp;the enormous potential for the recruitment of patients [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":1374,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"cybocfi_hide_featured_image":"","footnotes":""},"categories":[566,4],"tags":[267,182,181],"class_list":["post-1194","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-clinical-development","category-regulatory","tag-clinical-trial","tag-cofepris","tag-mexico"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.6 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Clinical Trial Regulatory Process - Mexico | Credevo Articles<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/credevo.com\/articles\/2018\/12\/02\/clinical-trial-regulatory-process-mexico\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Clinical Trial Regulatory Process - Mexico | Credevo Articles\" \/>\n<meta property=\"og:description\" content=\"Mexico is&nbsp;rapidly becoming a major player in the pharmaceutical and medical device industries. A recent report states that It\u2019s the number one exporter of medical devices in Latin America and 8th in the world&nbsp;and also a leading exporter of pharmaceutical products in Latin America. Having&nbsp;a diverse demographic profile&nbsp;gives&nbsp;the enormous potential for the recruitment of patients [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/credevo.com\/articles\/2018\/12\/02\/clinical-trial-regulatory-process-mexico\/\" \/>\n<meta property=\"og:site_name\" content=\"Credevo Articles\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/credevo\" \/>\n<meta property=\"article:published_time\" content=\"2018-12-02T05:00:35+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-09-20T11:52:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2018\/12\/Clinical_trial_regulatory_process_Procedure_Mexico_credevo.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Trial Expert\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@gocredevo\" \/>\n<meta name=\"twitter:site\" content=\"@gocredevo\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Trial Expert\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"8 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/credevo.com\/articles\/2018\/12\/02\/clinical-trial-regulatory-process-mexico\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/credevo.com\/articles\/2018\/12\/02\/clinical-trial-regulatory-process-mexico\/\"},\"author\":{\"name\":\"Trial Expert\",\"@id\":\"https:\/\/credevo.com\/articles\/#\/schema\/person\/27532d20071183286988a29ea878a2ec\"},\"headline\":\"Clinical Trial Regulatory Process &#8211; Mexico\",\"datePublished\":\"2018-12-02T05:00:35+00:00\",\"dateModified\":\"2021-09-20T11:52:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/credevo.com\/articles\/2018\/12\/02\/clinical-trial-regulatory-process-mexico\/\"},\"wordCount\":1723,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/credevo.com\/articles\/#organization\"},\"image\":{\"@id\":\"https:\/\/credevo.com\/articles\/2018\/12\/02\/clinical-trial-regulatory-process-mexico\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2018\/12\/Clinical_trial_regulatory_process_Procedure_Mexico_credevo.jpg\",\"keywords\":[\"clinical trial\",\"cofepris\",\"Mexico\"],\"articleSection\":[\"Clinical Development\",\"Regulatory\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/credevo.com\/articles\/2018\/12\/02\/clinical-trial-regulatory-process-mexico\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/credevo.com\/articles\/2018\/12\/02\/clinical-trial-regulatory-process-mexico\/\",\"url\":\"https:\/\/credevo.com\/articles\/2018\/12\/02\/clinical-trial-regulatory-process-mexico\/\",\"name\":\"Clinical Trial Regulatory Process - Mexico | Credevo Articles\",\"isPartOf\":{\"@id\":\"https:\/\/credevo.com\/articles\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/credevo.com\/articles\/2018\/12\/02\/clinical-trial-regulatory-process-mexico\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/credevo.com\/articles\/2018\/12\/02\/clinical-trial-regulatory-process-mexico\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2018\/12\/Clinical_trial_regulatory_process_Procedure_Mexico_credevo.jpg\",\"datePublished\":\"2018-12-02T05:00:35+00:00\",\"dateModified\":\"2021-09-20T11:52:29+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/credevo.com\/articles\/2018\/12\/02\/clinical-trial-regulatory-process-mexico\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/credevo.com\/articles\/2018\/12\/02\/clinical-trial-regulatory-process-mexico\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/credevo.com\/articles\/2018\/12\/02\/clinical-trial-regulatory-process-mexico\/#primaryimage\",\"url\":\"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2018\/12\/Clinical_trial_regulatory_process_Procedure_Mexico_credevo.jpg\",\"contentUrl\":\"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2018\/12\/Clinical_trial_regulatory_process_Procedure_Mexico_credevo.jpg\",\"width\":1920,\"height\":1080},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/credevo.com\/articles\/2018\/12\/02\/clinical-trial-regulatory-process-mexico\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/credevo.com\/articles\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Clinical Trial Regulatory Process &#8211; Mexico\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/credevo.com\/articles\/#website\",\"url\":\"https:\/\/credevo.com\/articles\/\",\"name\":\"Credevo\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/credevo.com\/articles\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/credevo.com\/articles\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/credevo.com\/articles\/#organization\",\"name\":\"Credevo Pte. Ltd.\",\"url\":\"https:\/\/credevo.com\/articles\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/credevo.com\/articles\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2021\/04\/CREDEVO-HORIZONTAL.jpg\",\"contentUrl\":\"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2021\/04\/CREDEVO-HORIZONTAL.jpg\",\"width\":320,\"height\":119,\"caption\":\"Credevo Pte. Ltd.\"},\"image\":{\"@id\":\"https:\/\/credevo.com\/articles\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/credevo\",\"https:\/\/x.com\/gocredevo\",\"https:\/\/www.instagram.com\/credevo_official\/\",\"https:\/\/www.linkedin.com\/company\/credevo\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/credevo.com\/articles\/#\/schema\/person\/27532d20071183286988a29ea878a2ec\",\"name\":\"Trial Expert\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/credevo.com\/articles\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/07b120d666645220d4fd5b49e154d849?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/07b120d666645220d4fd5b49e154d849?s=96&d=mm&r=g\",\"caption\":\"Trial Expert\"},\"url\":\"https:\/\/credevo.com\/articles\/author\/trialexpert\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Clinical Trial Regulatory Process - Mexico | Credevo Articles","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/credevo.com\/articles\/2018\/12\/02\/clinical-trial-regulatory-process-mexico\/","og_locale":"en_US","og_type":"article","og_title":"Clinical Trial Regulatory Process - Mexico | Credevo Articles","og_description":"Mexico is&nbsp;rapidly becoming a major player in the pharmaceutical and medical device industries. A recent report states that It\u2019s the number one exporter of medical devices in Latin America and 8th in the world&nbsp;and also a leading exporter of pharmaceutical products in Latin America. Having&nbsp;a diverse demographic profile&nbsp;gives&nbsp;the enormous potential for the recruitment of patients [&hellip;]","og_url":"https:\/\/credevo.com\/articles\/2018\/12\/02\/clinical-trial-regulatory-process-mexico\/","og_site_name":"Credevo Articles","article_publisher":"https:\/\/www.facebook.com\/credevo","article_published_time":"2018-12-02T05:00:35+00:00","article_modified_time":"2021-09-20T11:52:29+00:00","og_image":[{"width":1920,"height":1080,"url":"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2018\/12\/Clinical_trial_regulatory_process_Procedure_Mexico_credevo.jpg","type":"image\/jpeg"}],"author":"Trial Expert","twitter_card":"summary_large_image","twitter_creator":"@gocredevo","twitter_site":"@gocredevo","twitter_misc":{"Written by":"Trial Expert","Est. reading time":"8 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/credevo.com\/articles\/2018\/12\/02\/clinical-trial-regulatory-process-mexico\/#article","isPartOf":{"@id":"https:\/\/credevo.com\/articles\/2018\/12\/02\/clinical-trial-regulatory-process-mexico\/"},"author":{"name":"Trial Expert","@id":"https:\/\/credevo.com\/articles\/#\/schema\/person\/27532d20071183286988a29ea878a2ec"},"headline":"Clinical Trial Regulatory Process &#8211; Mexico","datePublished":"2018-12-02T05:00:35+00:00","dateModified":"2021-09-20T11:52:29+00:00","mainEntityOfPage":{"@id":"https:\/\/credevo.com\/articles\/2018\/12\/02\/clinical-trial-regulatory-process-mexico\/"},"wordCount":1723,"commentCount":0,"publisher":{"@id":"https:\/\/credevo.com\/articles\/#organization"},"image":{"@id":"https:\/\/credevo.com\/articles\/2018\/12\/02\/clinical-trial-regulatory-process-mexico\/#primaryimage"},"thumbnailUrl":"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2018\/12\/Clinical_trial_regulatory_process_Procedure_Mexico_credevo.jpg","keywords":["clinical trial","cofepris","Mexico"],"articleSection":["Clinical Development","Regulatory"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/credevo.com\/articles\/2018\/12\/02\/clinical-trial-regulatory-process-mexico\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/credevo.com\/articles\/2018\/12\/02\/clinical-trial-regulatory-process-mexico\/","url":"https:\/\/credevo.com\/articles\/2018\/12\/02\/clinical-trial-regulatory-process-mexico\/","name":"Clinical Trial Regulatory Process - Mexico | Credevo Articles","isPartOf":{"@id":"https:\/\/credevo.com\/articles\/#website"},"primaryImageOfPage":{"@id":"https:\/\/credevo.com\/articles\/2018\/12\/02\/clinical-trial-regulatory-process-mexico\/#primaryimage"},"image":{"@id":"https:\/\/credevo.com\/articles\/2018\/12\/02\/clinical-trial-regulatory-process-mexico\/#primaryimage"},"thumbnailUrl":"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2018\/12\/Clinical_trial_regulatory_process_Procedure_Mexico_credevo.jpg","datePublished":"2018-12-02T05:00:35+00:00","dateModified":"2021-09-20T11:52:29+00:00","breadcrumb":{"@id":"https:\/\/credevo.com\/articles\/2018\/12\/02\/clinical-trial-regulatory-process-mexico\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/credevo.com\/articles\/2018\/12\/02\/clinical-trial-regulatory-process-mexico\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/credevo.com\/articles\/2018\/12\/02\/clinical-trial-regulatory-process-mexico\/#primaryimage","url":"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2018\/12\/Clinical_trial_regulatory_process_Procedure_Mexico_credevo.jpg","contentUrl":"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2018\/12\/Clinical_trial_regulatory_process_Procedure_Mexico_credevo.jpg","width":1920,"height":1080},{"@type":"BreadcrumbList","@id":"https:\/\/credevo.com\/articles\/2018\/12\/02\/clinical-trial-regulatory-process-mexico\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/credevo.com\/articles\/"},{"@type":"ListItem","position":2,"name":"Clinical Trial Regulatory Process &#8211; Mexico"}]},{"@type":"WebSite","@id":"https:\/\/credevo.com\/articles\/#website","url":"https:\/\/credevo.com\/articles\/","name":"Credevo","description":"","publisher":{"@id":"https:\/\/credevo.com\/articles\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/credevo.com\/articles\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/credevo.com\/articles\/#organization","name":"Credevo Pte. Ltd.","url":"https:\/\/credevo.com\/articles\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/credevo.com\/articles\/#\/schema\/logo\/image\/","url":"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2021\/04\/CREDEVO-HORIZONTAL.jpg","contentUrl":"https:\/\/credevo.com\/articles\/wp-content\/uploads\/2021\/04\/CREDEVO-HORIZONTAL.jpg","width":320,"height":119,"caption":"Credevo Pte. Ltd."},"image":{"@id":"https:\/\/credevo.com\/articles\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/credevo","https:\/\/x.com\/gocredevo","https:\/\/www.instagram.com\/credevo_official\/","https:\/\/www.linkedin.com\/company\/credevo"]},{"@type":"Person","@id":"https:\/\/credevo.com\/articles\/#\/schema\/person\/27532d20071183286988a29ea878a2ec","name":"Trial Expert","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/credevo.com\/articles\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/07b120d666645220d4fd5b49e154d849?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/07b120d666645220d4fd5b49e154d849?s=96&d=mm&r=g","caption":"Trial Expert"},"url":"https:\/\/credevo.com\/articles\/author\/trialexpert\/"}]}},"_links":{"self":[{"href":"https:\/\/credevo.com\/articles\/wp-json\/wp\/v2\/posts\/1194"}],"collection":[{"href":"https:\/\/credevo.com\/articles\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/credevo.com\/articles\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/credevo.com\/articles\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/credevo.com\/articles\/wp-json\/wp\/v2\/comments?post=1194"}],"version-history":[{"count":41,"href":"https:\/\/credevo.com\/articles\/wp-json\/wp\/v2\/posts\/1194\/revisions"}],"predecessor-version":[{"id":6896,"href":"https:\/\/credevo.com\/articles\/wp-json\/wp\/v2\/posts\/1194\/revisions\/6896"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/credevo.com\/articles\/wp-json\/wp\/v2\/media\/1374"}],"wp:attachment":[{"href":"https:\/\/credevo.com\/articles\/wp-json\/wp\/v2\/media?parent=1194"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/credevo.com\/articles\/wp-json\/wp\/v2\/categories?post=1194"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/credevo.com\/articles\/wp-json\/wp\/v2\/tags?post=1194"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}